Literature DB >> 31191191

Infectious Screening of Blood Components: Is There Still a Need for Further Inventions?

Jens Dreier1, Tanja Vollmer1.   

Abstract

Year:  2019        PMID： 31191191      PMCID： PMC6514485          DOI： 10.1159/000499351

Source DB:  PubMed          Journal:  Transfus Med Hemother        ISSN： 1660-3796            Impact factor:   3.747


× No keyword cloud information.
  3 in total

1.  Red blood cell concentrates treated with the amustaline (S-303) pathogen reduction system and stored for 35 days retain post-transfusion viability: results of a two-centre study.

Authors:  J A Cancelas; J L Gottschall; N Rugg; S Graminske; M A Schott; A North; N Huang; N Mufti; A Erickson; S Rico; L Corash
Journal:  Vox Sang       Date:  2017-02-21       Impact factor: 2.144

2.  Europe's new hepatitis problem.

Authors:  Kai Kupferschmidt
Journal:  Science       Date:  2016-08-25       Impact factor: 47.728

Review 3.  Pathogen reduction of whole blood: utility and feasibility.

Authors:  J-P Allain; R Goodrich
Journal:  Transfus Med       Date:  2017-09-05       Impact factor: 2.019
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.